This repurposed antidepressant was recently approved in ADHD, but how does it compare with other treatments?

Sleepwalking is a rare side effect on psychiatric medications, particularly hypnotics and antidepressants. A new analysis explores whether lithium and the antipsychotics should be added to that list.

Clinicians and families often seek natural non-pharmacological approaches to ADHD in children and adolescents. This hope has spawned a growing body of preliminary research on many supplements and diets for ADHD. This research update on a study of the DASH diet offers our thinking about its possible usefulness for our patients.

Randomized controlled trials have not been kind to commercial pharmacogenetic panels, but will Genecept’s fate be any different?

We all need to become more aware of the differences in the population prevalence of mental health problems among various communities. This research update offers more recent data, upending what we knew when DSM-5 came out, and giving us a better sense of how to assess black youth and avoiding bias in the diagnostic process.

The idea that good sleep promotes mental health has led researchers to test whether hypnotics have psychiatric benefits beyond their effects on sleep.

Previous trials of baclofen for alcohol use disorder have used fixed or rather low doses, and the results have been mixed. This was the first randomized trial to allow up-titration of the dose depending on the patient’s response.

The link between ADHD and antisocial behavior leading to arrests and incarcerations is often not clear: is the ADHD causing the behaviors or other related factors? We examine the results of a population-based study to give us insight into whether treating ADHD with stimulant medication has an effect on the risk of criminal behavior.

We examine current methylphenidate dosing and unpack what the research tells us about prescribing beyond conventional limits when clinically indicated for children and adolescents.

Why does stroke matter in bipolar disorder? Because it’s the leading cause of death for these patients. Some mood stabilizers raise the stroke risk, while others do not.